ASIT Biotech S.A. Announced earnings results for the half year ended June 30, 2020. For the half year, the company announced operating loss was EUR 1.108 million compared to EUR 7.809 million a year ago. Net loss was EUR 1.218 million compared to EUR 7.824 million a year ago.